Medication info
Simvam 20 mg Tablets (Simvastatin)

Simvam 20 mg Tablets (Simvastatin)

Prescription medicationTabletOral
Ingredient · strength
Simvastatin›20mg / 1 tablet
Manufacturer / importer
McNulty Pharmaceutical Co., Ltd.
Appearance
Brownish yellow oval film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201603133 · Approved 2016.05.31

Summary

Main use
Improvement of hyperlipidemia, improvement of pediatric familial hypercholesterolemia, prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
1. Reduction of risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to coronary heart disease, diabetes, peripheral vascular disease, stroke, or a history of other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Risk reduction in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. The recommended dose is 5 ~ 40 mg of this medicine once daily in the evening. Adjust the dose appropriately according to the baseline LDL cholesterol level before starting treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, the 80 mg dose of this medicine should be used only in patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity, particularly during the first year of treatment (see section 1. Warnings under Precautions for Use). 2) See below for recommended doses in patients taking this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, older adults, and patients with renal impairment) (see section 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Results of controlled clinical trials indicate that patients with homozygous familial hypercholesterolemia should take 40 mg of this medicine once daily in the evening. Use this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not possible. (2) In older adults, a daily dose of 20 mg of this medicine may achieve the maximum cholesterol-lowering effect. (3) Use in patients taking verapamil, diltiazem, or dronedarone When this medicine is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg daily. (4) Use in patients taking amiodarone, amlodipine, or ranolazine When this medicine is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see section 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine should not exceed 10 mg daily. (6) Use in patients with renal impairment Because this medicine is not extensively excreted by the kidneys, no dose adjustment is necessary in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, start with an initial dose of 5 mg daily and monitor closely.
Child dose
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily.

Ingredients

Manufacturer
McNulty Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia, improvement of pediatric familial hypercholesterolemia, prevention of cardiovascular disease

  • Coronary heart disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • other cerebrovascular diseases
  • hypercholesterolemia
  • dyslipidemia
  • dysbetalipoproteinemia
  • hypertriglyceridemia
  • heterozygous familial hypercholesterolemia
View approved original text

This drug helps reduce the risk of mortality from coronary heart disease, non-fatal myocardial infarction, and stroke, and the risk of vascular interventions in adult patients with a high risk of cardiovascular disease. It also lowers total cholesterol, LDL cholesterol, apolipoprotein B, and triglyceride levels in patients with various types of hyperlipidemia and increases HDL cholesterol levels, which is considered the 'good' cholesterol. This medication is used as an adjunct to dietary therapy for various dyslipidemias, including familial hypercholesterolemia. It is particularly effective in pediatric patients aged 10 to 17 with heterozygous familial hypercholesterolemia. Thus, it is beneficial for maintaining heart health and improving blood lipid levels, contributing to the overall prevention and treatment of cardiovascular diseases.

How to take

Adult dose

1. Reduction of risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to coronary heart disease, diabetes, peripheral vascular disease, stroke, or a history of other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Risk reduction in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. The recommended dose is 5 ~ 40 mg of this medicine once daily in the evening. Adjust the dose appropriately according to the baseline LDL cholesterol level before starting treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, the 80 mg dose of this medicine should be used only in patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity, particularly during the first year of treatment (see section 1. Warnings under Precautions for Use). 2) See below for recommended doses in patients taking this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, older adults, and patients with renal impairment) (see section 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Results of controlled clinical trials indicate that patients with homozygous familial hypercholesterolemia should take 40 mg of this medicine once daily in the evening. Use this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not possible. (2) In older adults, a daily dose of 20 mg of this medicine may achieve the maximum cholesterol-lowering effect. (3) Use in patients taking verapamil, diltiazem, or dronedarone When this medicine is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg daily. (4) Use in patients taking amiodarone, amlodipine, or ranolazine When this medicine is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see section 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine should not exceed 10 mg daily. (6) Use in patients with renal impairment Because this medicine is not extensively excreted by the kidneys, no dose adjustment is necessary in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, start with an initial dose of 5 mg daily and monitor closely.

Child dose

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily.

Precautions

This medication may cause muscle-related side effects such as myopathy and rhabdomyolysis, especially when taken at high doses, and therefore caution should be exercised. If unexplained muscle pain, tenderness, or weakness occur during treatment, the physician must be informed immediately. This drug is mainly metabolized in the liver, so patients with poor liver function should avoid or use it cautiously. Women who are pregnant, might become pregnant, or are nursing should not take this medication. When taken with certain specific medications, the blood concentration of this drug may increase, raising the risk of muscle-related side effects; therefore, it is necessary to discuss adjusting the dosage or using an alternative medication with a physician. Special caution should be taken when used in combination with strong CYP3A4 inhibitors, gemfibrozil, cyclosporine, danazol, certain antifungals, antibiotics, calcium channel blockers, etc. Elderly patients, women, patients with reduced renal or thyroid function, and those with a history of muscle diseases need to be more careful while taking this medication. It is advisable to have liver function tests and muscle-related tests regularly while on this drug. In case of overdose, seek medical attention immediately, and this medication should be kept out of the reach of children.

Side effects

  • Myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 88 more
  • upper respiratory infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • muscle cramps
  • arthralgia
  • dysgeusia
  • extraocular muscle dysfunction
  • facial paresis
  • tremor
  • sensory abnormalities
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disorders
  • nightmares
  • depression
  • cognitive impairment
  • severe myasthenia gravis
  • ocular myasthenia
  • hepatitis
  • liver dysfunction
  • jaundice
  • pancreatitis
  • liver failure
  • choledocholithiasis-related jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • loss of appetite
  • vomiting
  • alopecia areata
  • pruritus
  • skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • cataract progression
  • ocular muscle paralysis
  • anemia
  • elevation of aminotransferases
  • elevated ALP
  • increased γ-GTP
  • high bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • interstitial lung disease
  • anaphylaxis
  • angioedema
  • lupus erythematosus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • toxic epidermal necrolysis
  • mucocutaneous syndrome
  • erythema multiforme
  • sensory numbness in limbs
  • tingling
  • cold sensation
  • thrombocytopenia
  • fever
  • chills

Not everyone experiences these, and they can vary from person to person.

Storage

This drug must be stored in a closed container to prevent exposure to air or light, and it is important to store it at room temperature between 1 and 30 degrees Celsius. Proper storage helps to maintain the drug's effectiveness and safety.

Appearance and packaging

Appearance

Brownish yellow oval film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.